Recent advances in carbohydrate-based paclitaxel delivery systems

Paclitaxel (PTX) as the most important member of the taxane family is used against a wide range of cancers including breast, ovarian and lung cancers. However, the effectiveness of PTX in clinical practice is limited by its low water solubility and permeability in biological tissues. To address thes...

Full description

Saved in:
Bibliographic Details
Published in:Polymer bulletin (Berlin, Germany) Germany), 2024, Vol.81 (2), p.1043-1069
Main Authors: Ramezanpour, Azar, Ansari, Legha, Rahimkhoei, Vahid, Sharifi, Sina, Bigham, Ashkan, Lighvan, Zohre Mehri, Rezaie, Jafar, Szafert, Sławomir, Mahdavinia, GholamReza, Akbari, Ali, Jabbari, Esmaiel
Format: Article
Language:English
Subjects:
Characterization and Evaluation of Materials
Chemistry
Chemistry and Materials Science
Complex Fluids and Microfluidics
Organic Chemistry
Physical Chemistry
Polymer Sciences
Review Paper
Soft and Granular Matter
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Paclitaxel (PTX) as the most important member of the taxane family is used against a wide range of cancers including breast, ovarian and lung cancers. However, the effectiveness of PTX in clinical practice is limited by its low water solubility and permeability in biological tissues. To address these limitations, PTX is formulated with Cremophor EL and dehydrated ethanol, known as Taxol®. Due to the adverse side effects of the formulation, efforts have been made in recent years to develop alternative PTX formulations. Polysaccharides, due to their low toxicity and biocompatibility, biodegradability, and ease of chemical modification are an excellent alternative to Cremophor EL for formulating PTX. This review focuses on recent advances to develop PTX formulations based on polysaccharides.
ISSN:0170-0839
1436-2449
DOI:10.1007/s00289-023-04759-9